Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HACHE: Human Albumin in Overt Hepatic Encephalopathy
NCT06483737Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of albumin (human) in hepatic encephalopathy (HE) (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Change of overt HE. Started Jun 2025; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT06483737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06483737.